Variant report
Variant | esv12044 |
---|---|
Chromosome Location | chr8:54510310-54518345 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560192591 | chr8:54510322-54510323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11778297 | chr8:54510378-54510379 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs113434729 | chr8:54510399-54510400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552386965 | chr8:54510409-54510410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10808882 | chr8:54510435-54510436 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs138471201 | chr8:54510482-54510483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548418608 | chr8:54510488-54510489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149632013 | chr8:54510503-54510504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10958376 | chr8:54510549-54510550 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs193002341 | chr8:54510584-54510585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10958377 | chr8:54510605-54510606 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs79397904 | chr8:54510627-54510628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375656105 | chr8:54510631-54510632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557347193 | chr8:54510665-54510666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10958378 | chr8:54510701-54510702 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs542118674 | chr8:54510708-54510709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71735466 | chr8:54510736-54510737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs199726508 | chr8:54510737-54510738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562364416 | chr8:54510748-54510749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144403480 | chr8:54510749-54510750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540205387 | chr8:54510760-54510761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560026789 | chr8:54510798-54510799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532262634 | chr8:54510817-54510818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7461405 | chr8:54510848-54510849 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs182881166 | chr8:54510868-54510869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114263953 | chr8:54510916-54510917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548228414 | chr8:54510956-54510957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568341231 | chr8:54510972-54510973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71501578 | chr8:54510982-54510983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6473859 | chr8:54510983-54510984 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs117259351 | chr8:54511016-54511017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539565410 | chr8:54511022-54511023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6473860 | chr8:54511076-54511077 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs576235902 | chr8:54511144-54511145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186524020 | chr8:54511180-54511181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374315968 | chr8:54511187-54511188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555817251 | chr8:54511213-54511214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191808182 | chr8:54511264-54511265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541330073 | chr8:54511314-54511315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553826096 | chr8:54511335-54511336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549367431 | chr8:54511355-54511356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs6989219 | chr8:54511360-54511361 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs562562677 | chr8:54511399-54511400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141527082 | chr8:54511405-54511406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs367644925 | chr8:54511450-54511451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372275530 | chr8:54511480-54511481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531583201 | chr8:54511482-54511483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11783135 | chr8:54511512-54511513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs561868448 | chr8:54511550-54511551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76102325 | chr8:54511562-54511563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:54503400-54510600 | Weak transcription | Aorta | Aorta |
2 | chr8:54510600-54510800 | Enhancers | Aorta | Aorta |
3 | chr8:54510800-54511200 | Weak transcription | Aorta | Aorta |
4 | chr8:54511200-54511400 | Enhancers | Aorta | Aorta |
5 | chr8:54511400-54516000 | Weak transcription | Aorta | Aorta |
6 | chr8:54516000-54516200 | Enhancers | Aorta | Aorta |